Inventor · disambiguated record
Jean-Frederic Colombel
Also filed as: COLOMBEL JEAN-FREDERIC
4 granted patents·5 pending applications·55 citations·filing 2002–2021
76Inventor score
Files withCHRU LILLE2ICAHN SCHOOL MED MOUNT SINAI2MILLENNIUM PHARM INC2COLOMBEL JEAN-FREDERIC1UNIV DU DROIT ET DE LA SANTE DE LILLE 21
Top patents by PatentIndex Score
9 records- 0189US10918716B2Triple combination therapy for treating Crohn's diseaseMILLENNIUM PHARM INC·Filed 2017·Granted Feb 16, 2021·11 cites·18 claims
- 0286US12246064B2Method of treating Crohn's disease by administering a triple combination therapy of anti-integrin antibody, adalimumab and methotrexateMILLENNIUM PHARM INC·Filed 2021·Granted Mar 11, 2025·2 cites·15 claims
- 0383US9593313B228 kDa GST proteins from schistosoma for the use thereof in the treatment of inflammatory autoimmune diseases generating a Th1 and/or Th17 responseUNIV DU DROIT ET DE LA SANTE DE LILLE 2·Filed 2013·Granted Mar 14, 2017·32 cites·10 claims
- 0477US7109182B2Synthetic oligomannosides, preparation and uses thereofCHRU LILLE·Filed 2002·Granted Sep 19, 2006·10 cites·12 claims
- 0549US2023405086A1Compositions and methods for preventing, detecting, and treating inflammatory bowel diseaseICAHN SCHOOL MED MOUNT SINAI·Filed 2021·Application pending·0 cites
- 0647US2006270627A1Synthetic oligomannosides, preparation and uses thereofCHRU LILLE·Filed 2006·Application pending·0 cites
- 0745US2024044916A1Methods of monitoring inflammatory bowel diseasesICAHN SCHOOL MED MOUNT SINAI·Filed 2021·Application pending·0 cites
- 0835US2006051353A1Methods and compositions to evaluate antibody treatment responseCOLOMBEL JEAN-FREDERIC·Filed 2005·Application pending·0 cites
- 0935US2004132110A1Method for diagnosing chronic intestinal inflammatory diseasesFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean-Frederic Colombel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →